MedPage Today on MSN1 天
SGLT2i Improves Outcomes After TAVI
As heart failure patients, the TAVI population studied already is recommended to be treated with an SGLT2 inhibitor, noted ...
Omeros has announced that the activation of clinical trial sites for patient enrolment is now in progress for its Phase III ...
According to Straits Research, The Mold Inhibitors Market size was valued at USD XX Billion in 2023 to USD 3.03 Billion by ...
US regulators have once again declined to approve Hengrui Pharmaceuticals' (SHA: 600276) PD-1 inhibitor camrelizumab, further delaying the drug's entry into the American market.
Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...
Assembly Biosciences (NASDAQ:ASMB – Get Free Report)‘s stock had its “neutral” rating reiterated by stock analysts at HC ...
Guggenheim initiated coverage on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a report released on Tuesday morning, Marketbeat reports. The brokerage issued a buy rating and a $31.00 ...
If you're tired of waiting in long lines after traveling abroad, you might want to apply for Global Entry — especially if your credit card reimburses you for the application fee. Issued by U.S ...
This program is for domestic use only, so there are no international airport locations. Global Entry is a membership program run by U.S. Customs and Border Protection. The program provides ...
Personal and small business cards issued by U.S. Bank and Bank of America cards are currently not available on CNBC Select and links have been redirected to our credit card marketplace where you ...